| ‘ZS-MDR-TB’ versus ‘ZR-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility Y Zhang, KC Chang, CC Leung, WW Yew, B Gicquel, D Fallows, ... Emerging microbes & infections 1 (7), e5, 2012 | 45 | 2012 |
| 105 Efavirenz Pharmacokinetics in HIV+ Persons Receiving Rifapentine and Isoniazid for TB Prevention AT Podany, Y Bao, RE Chaisson, S Swindells, JW Andersen, T Mwelase, ... | 3 | 2014 |
| 1125 Hepatotoxicity associated with the antiretroviral therapy (ART) containing protease inhibitors (PIS) with or without pharmacokinetic boosting by low-dose ritonavir (RTV) MS Sulkowski, DL Thomas, SH Mehta, RE Chaisson, RD Moore Hepatology, 698, 2003 | 6 | 2003 |
| 1997USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus JE Kaplan, H Masur, KK Holmes MMWR Morb Mortal Wkly Rep 48, 1-59, 1999 | 846* | 1999 |
| 288 Extrême efficacité du traitement de la tuberculose murine par la moxifloxacine (M) E Nuermberger, T Yoshimatsu, S Tyagi, R Chaisson, W Bishai, J Grosset Revue des Maladies Respiratoires 21, 104, 2004 | | 2004 |
| 7 1 Epiglottitis in Adults RE Chaisson Respiratory infections 5, 127, 1986 | | 1986 |
| 70 years of TB Prevention: Efficacy, Effectiveness, Toxicity, Durability and Duration. N Salazar-Austin, DW Dowdy, RE Chaisson, JE Golub American journal of epidemiology, 2019 | | 2019 |
| 93 A Phase 2 Trial of a Rifapentine Plus Moxifloxacin-Based Regimen for Pulmonary TB Treatment MB Conde, SC Cavalcante, M Dalcolmo, F Mello, R Duarte, C Loredo, ... | 1 | 2014 |
| A call to action for concentrated HIV epidemics C Beyrer, SD Baral, B Weir, JW Curran, RE Chaisson, P Sullivan Current Opinion in HIV and AIDS 9 (2), 95, 2014 | 24 | 2014 |
| A cluster randomized trial of provider-initiated (Opt-out) HIV counseling and testing of tuberculosis patients in South Africa DS Pope, AN DeLuca, P Kali, H Hausler, C Sheard, E Hoosain, ... Journal of acquired immune deficiency syndromes (1999) 48 (2), 190, 2008 | 68 | 2008 |
| A defect in innate host immunity among HIV-seronegative persons with extrapulmonary tuberculosis TR Sterling, SE Dorman, RE Chaisson, J Hackman, K Moore, SM Holland CLINICAL INFECTIOUS DISEASES 31 (1), 310-310, 2000 | | 2000 |
| A diagonal approach to building primary healthcare systems in resource‐limited settings: women‐centred integration of HIV/AIDS, tuberculosis, malaria, MCH and NCD initiatives CR Gounder, RE Chaisson Tropical Medicine & International Health 17 (12), 1426-1431, 2012 | 32 | 2012 |
| A implantação da estratégia DOTS na cidade do Rio de Janeiro SC Cavalcante, ECC Soares, MS Rocha, JR Oliveira, SMO Dias, ... Pulmäo RJ 12 (2), 71-79, 2003 | 4 | 2003 |
| A multi-state outbreak of tuberculosis among members of a highly mobile social network: implications for tuberculosis elimination TR Sterling, D Thompson, RL Stanley, PD McElroy, A Madison, K Moore, ... The International Journal of Tuberculosis and Lung Disease 4 (11), 1066-1073, 2000 | 70 | 2000 |
| A phase 2 randomized trial of a rifapentine plus moxifloxacin-based regimen for treatment of pulmonary tuberculosis MB Conde, FCQ Mello, RS Duarte, SC Cavalcante, V Rolla, M Dalcolmo, ... PLoS One 11 (5), e0154778, 2016 | 21 | 2016 |
| A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated … CA Benson, PL Williams, JS Currier, F Holland, LF Mahon, ... Clinical Infectious Diseases 37 (9), 1234-1243, 2003 | 140 | 2003 |
| A randomized trial of 2 months of rifampin (RIF) and pyrazinamide (PZA) versus 12 months of isoniazid (INH) for the prevention of tuberculosis (TB) in HIV–positive (+), PPD+ … F Gordin, R Chaisson, J Matts CONFERENCE ON RETRO-VIRUSES AND, 1998 | 19 | 1998 |
| A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users RE Chaisson, GL Barnes, J Hackman, L Watkinson, LK Lpn, S Metha, ... The American journal of medicine 110 (8), 610-615, 2001 | 115 | 2001 |
| A trial of mass isoniazid preventive therapy for tuberculosis control GJ Churchyard, KL Fielding, JJ Lewis, L Coetzee, EL Corbett, ... New England Journal of Medicine 370 (4), 301-310, 2014 | 182 | 2014 |
| A-111 Controlling the impact of HIV-related tuberculosis R Chaisson JAIDS Journal of Acquired Immune Deficiency Syndromes 71, 39, 2016 | | 2016 |
Jonathan GolubAssociate Professor, Johns Hopkins UniversityVerified email at jhmi.edu
